The acquisition is expected to create a new business segment for Symmetry Medical with more than $100 million in combined annual sales in the worldwide market for general surgical implants. Under the agreement, Symmetry will acquire Codman & Shurtleff’s product portfolio for $165 million in cash. Codman will provide translational services to Symmetry for a period of time following the transaction’s closing.
Symmetry intends to finance the acquisition through an amendment to its Senior Secured Credit Facility and the issuance of $65 million of senior subordinated notes. The transaction is expected to close by the end of 2011.
Related Articles on Orthopedic Device Companies:
Small Bone Innovations Secures $43M Credit Facility
Exactech Launches Gibralt Spinal System
X-Spine Receives FDA Clearance for Interspinous Fusion
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.